Under construction – not a live service
Sign in
CompletedNo phase

Sensorimotor Integration in Patients With Tourette Syndrome

Key facts

Who runs it
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
60 people enrolled
Started
20 Mar 2025
Ended
3 Dec 2025
Type of study
Observational, 2 groups
Record updated
18 December 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • For Tourette Syndrome group:
  • Clinical diagnosis of Tourette Syndrome (TS) according to DSM-5 criteria
  • Age between 18 and 65 years
  • Ability to understand and comply with study procedures
  • Written informed consent provided; For Healthy Control group:
  • No current or past history of neurological or psychiatric disorders
  • Age between 18 and 65 years
  • Matched to the TS group for age, sex, and education level
  • Ability to understand and comply with study procedures
  • Written informed consent provided

Who cannot take part

  • History of significant neurological disorders (e.g., brain injury or dementia) or major psychiatric disorders (with the exception of conditions commonly associated with Tourette Syndrome, such as Obsessive-Compulsive Disorder, ADHD, depression, and anxiety)
  • Failure or refusal to provide written informed consent
  • Confirmed pregnancy (self-reported) and/or breastfeeding

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The present study investigates the mechanisms underlying the sense of agency in patients with Tourette Syndrome (TS). Previous research has shown that individuals with TS display impairments in both explicit and implicit aspects of agency, possibly due to altered integration between sensory feedback and motor predictions. To explore this hypothesis, the study will examine the phenomenon of sensory attenuation, a marker of sensorimotor integration that has not yet been investigated in this population. Furthermore, the study will assess how alterations in sensorimotor integration are related to the severity of TS symptoms.

The 2 groups in the trial

  • Tourette Syndrome Patients

    Patients affected by Tourette Syndrome

  • Healthy controls

    Individuals without neurological or psychiatric disorders

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Sensorimotor Integration in Patients With Tourette Syndrome: an Observational Study.
Record updated
18 December 2025